IL13RA2 and glioblastoma: Xie’s group utilized glucose-coated ultra-small superparamagnetic iron oxide nanoparticles (USPIOs) to label anti-hEGFRvIII/IL13Rα2 CAR-T cells, enabling non-invasive MRI monitoring of their infiltration and persistence in glioblastoma.